Théa and Galimedix, Inc sign a new partnership
Théa and Gallimedix, Inc sign a new partnership
©Zhiguo He
Théa and Gallimedix, Inc sign a new partnership
Théa Open Innovation and CURACLE sign a new partnership
Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics sign an exclusive licensing, co development and commercialization agreement
Théa and Coave Therapeutics announce their partnership
Théa Open Innovation signs an exclusive Licensing Agreement for the rights on Ripple Therapeutics Corporation lead product, IBE-814 for North America and Europe.
EVEON, designer and maker of medical devices for the preparation and administration of drugs, and Théa, European leader in the field of ophthalmology, announce their partnership in the development of innovative medical technologies.
OliX Pharmaceuticals Announces Expansion of Collaboration with Laboratoires Théa to Develop siRNA Therapeutics for Ophthalmic Diseases.
BIOCORP, a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems, announces the signature of a partnership agreement with Théa.